3.5.3 Intramuscular oxytocin administration
Use of any intramuscular oxytocic before the birth of the infant
is generally regarded as dangerous, because the dosage cannot be adapted to the
level of uterine activity. Hyperstimulation may result and is harmful to the
fetus. An increase in the incidence of ruptured uterus, with corresponding grave
sequelae, has also been linked to this practice (Kone 1993, Zheng 1994).
Nevertheless intramuscular oxytocin administration is still practised, sometimes
at the request of pregnant women or her family expecting a more rapid delivery.
In some developing countries the drug can be bought on the market. This harmful
practice should be abandoned. The same holds true for the administration of
other oxytocics, like prostaglandins, at any time before delivery in such a way
that their effect cannot be